The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma
Open accessAbstract
OBJECTIVE: To determine the prognostic significance of histologic type/subtype in a large series of patients with primary resected retroperitoneal sarcoma. BACKGROUND: The histologic diversity and rarity of retroperitoneal sarcoma has hampered the ability to predict patient outcome. METHODS: From a single-institution, prospective database, 675 patients treated surgically for primary, nonmetastatic retroperitoneal sarcoma during 1982 to 2010 were identified and histologic type/subtype was reviewed. Clinicopathologic variables were analyzed for association with disease-specific death (DSD), local recurrence (LR), and distant recurrence (DR). RESULTS: Median follow-up for survivors was 7.5 years. The predominant histologies were well-differentiated liposarcoma, dedifferentiated liposarcoma, and leiomyosarcoma. Five-year cumulative incidence of DSD was 31%, and factors independently associated with DSD were R2 resection, resection of 3 or more contiguous organs, and histologic type. Five-year cumulative incidence for LR was 39% and for DR was 24%. R1 resection, age, tumor size, and histologic type were independently associated with LR; size, resection of 3 or more organs, and histologic type were independently associated with DR. Liposarcoma and leiomyosarcoma were associated with late recurrence and DSD (as long as 15 years from diagnosis). For solitary fibrous tumor, LR was uncommon (<10%), but early distant recurrence was common (36% at 5 years). Nomograms were developed to predict DSD, LR, and DR. CONCLUSIONS: Histologic type/subtype is the most important independent predictor of DSD, LR, and DR in primary retroperitoneal sarcoma. Histology predicts the pattern and incidence of LR and DR and will aid in more accurate patient counseling and selection of patients for adjuvant therapy trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Singer, S., Antonescu, C. R., Riedel, E., & Brennan, M. F. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000086542.11899.38 · Cited by 670
Self-citationBonvalot, S., Rivoire, M., Castaing, M., Stoeckle, E., Le Cesne, A., Blay, J. Y., & Laplanche, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0802 · Cited by 644
Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction
Wolbers, M., Koller, M. T., Witteman, J. C. M., & Steyerberg, E. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a39056 · Cited by 625
Postoperative Nomogram for 12-Year Sarcoma-Specific Death
Kattan, M. W., Leung, D. H. Y., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.791 · Cited by 609
Self-citationDalal, K. M., Kattan, M. W., Antonescu, C. R., Brennan, M. F., & Singer, S. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000234795.98607.00 · Cited by 421
Self-citationGronchi, A., Miceli, R., Shurell, E., Eilber, F. C., Eilber, F. R., Anaya, D. A., Kattan, M. W., Honoré, C., Lev, D. C., Colombo, C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.3747 · Cited by 335
Bonvalot, S., Miceli, R., Berselli, M., Causeret, S., Colombo, C., Mariani, L., Bouzaiene, H., Le Péchoux, C., Casali, P. G., Le Cesne, A., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1057-5 · Cited by 331
Singer, S., Socci, N. D., Ambrosini, G., Sambol, E., Decarolis, P., Wu, Y., O'Connor, R., Maki, R., Viale, A., Sander, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0584 · Cited by 250
Self-citation
Cited by
Gronchi, A., Strauss, D. C., Miceli, R., Bonvalot, S., Swallow, C. J., Hohenberger, P., Van Coevorden, F., Rutkowski, P., Callegaro, D., Hayes, A. J., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001447 · Cited by 552
Nacev, B. A., Sanchez-Vega, F., Smith, S. A., Antonescu, C. R., Rosenbaum, E., Shi, H., Tang, C., Socci, N. D., Rana, S., Gularte-Mérida, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30453-x · Cited by 232
Self-citationAngeles, C. V., Velez, A., Rios, J., Laxa, B., Shum, D., Ruiz, P. D., Shen, Y., Ostrovnaya, I., Gularte-Mérida, R., Nacev, B. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2486 · Cited by 13
Self-citationTargeting eIF4A-dependent translation in genetically complex sarcoma
Kim, Y.-M., Mohan, P., Sehrawat, U., Seffar, E., De Queiroz, R. M., Chadalavada, K., Persaud, N., Okada, T., Kulkarni, A., Lin, J., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.192936
Self-citation
Metadata
- Authors
- Tan, M. C. B., Brennan, M. F., Kuk, D., Agaram, N. P., Antonescu, C. R., Qin, L.-X., Moraco, N., Crago, A. M., & Singer, S.
- Venue
- Annals of Surgery
- Published
- 2016-03
- Volume
- 263
- Issue
- 3
- Pages
- 593-600
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2318872159
- Cited by
- 357
- References
- 22
- FWCI
- 18.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. https://app.cochat.ai/papers/10.1097/sla.0000000000001149
- The paper
- Tan, M. C. B., Brennan, M. F., Kuk, D., Agaram, N. P., Antonescu, C. R., Qin, L.-X., Moraco, N., Crago, A. M., & Singer, S. (2016). Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Annals of Surgery. https://doi.org/10.1097/sla.0000000000001149
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.